Back
Pliant Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
40
PLRX
Pliant Therapeutics, Inc.
Last Price:
$1.30
Seasonality Move:
-20.45%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight selling pressure.
Pliant Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Buy |
| 20-day SMA: | 1.25 | Buy |
| 50-day SMA: | 1.44 | Sell |
| 200-day SMA: | 1.48 | Sell |
| 8-day EMA: | 1.26 | Buy |
| 20-day EMA: | 0.98 | Buy |
| 50-day EMA: | 0.57 | Buy |
| 200-day EMA: | 0.17 | Buy |
Pliant Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 50.57 | Buy |
| Chaikin Money Flow: | -714396 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.2 - 1.34) | Buy |
| Bollinger Bands (100): | (1.34 - 1.68) | Sell |
Pliant Therapeutics, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics, Inc. Stock
Is Pliant Therapeutics, Inc. Stock a Buy?
-
Pliant Therapeutics, Inc. share price is 1.32 while PLRX 8-day simple moving average is 1.28, which is a Buy signal.
-
The stock price of PLRX is 1.32 while Pliant Therapeutics, Inc. 20-day SMA is 1.25, which makes it a Buy.
-
Pliant Therapeutics, Inc. 50-day simple moving average is 1.44 while PLRX share price is 1.32, making it a Sell technically.
-
PLRX stock price is 1.32 and Pliant Therapeutics, Inc. 200-day simple moving average is 1.48, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
40
Pliant Therapeutics, Inc. (PLRX)
is a Sell
Is Pliant Therapeutics, Inc. a Buy or a Sell?
-
Pliant Therapeutics, Inc. stock is rated a SellThe current Pliant Therapeutics, Inc. [PLRX] share price is $1.32. The Score for PLRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics, Inc. Stock Info
Market Cap:
81.1M
Price in USD:
1.32
Share Volume:
1.4M
Pliant Therapeutics, Inc. 52-Week Range
52-Week High:
12.88
52-Week Low:
1.10
Sell
40
Pliant Therapeutics, Inc. (PLRX)
is a Sell
Pliant Therapeutics, Inc. Share Price Forecast
-
What is the Pliant Therapeutics, Inc. stock price today?The Pliant Therapeutics, Inc. stock price is 1.32 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics, Inc. is overvalued.
Is Pliant Therapeutics, Inc. Stock a Buy?
-
Pliant Therapeutics, Inc. share price is 1.32 while PLRX 8-day exponential moving average is 1.26, which is a Buy signal.
-
The stock price of PLRX is 1.32 while Pliant Therapeutics, Inc. 20-day EMA is 0.98, which makes it a Buy.
-
Pliant Therapeutics, Inc. 50-day exponential moving average is 0.57 while PLRX share price is 1.32, making it a Buy technically.
-
PLRX stock price is 1.32 and Pliant Therapeutics, Inc. 200-day simple moving average is 0.17, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics, Inc.
Is Pliant Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.36 per share.
Technical Analysis of Pliant Therapeutics, Inc.
Should I short Pliant Therapeutics, Inc. stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is 0.31, suggesting Pliant Therapeutics, Inc. is a Buy
-
Pliant Therapeutics, Inc. Relative Strength Index (RSI) is 50.57, which suggest Pliant Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Pliant Therapeutics, Inc. is (1.2 - 1.34), which suggest Pliant Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Pliant Therapeutics, Inc. is (1.34 - 1.68), which suggest Pliant Therapeutics, Inc. is a Sell
* Pliant Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.